IPM 034
Status:Completed
Phase:I
Principal Investigator(s):
Objective:An Open-label, Parallel-group Pharmacokinetic Trial in Healthy HIV-negative Women to Characterize the Release Profile of Dapivirine Delivered by a Silicone Matrix Ring (Ring 004), Containing 25 mg of Dapivirine, Over Various Ring Use Periods.
Prevention Option(s):Microbicides
Study Design:
Arms and Assigned Interventions
Description
Mode of Delivery
ARMs
Official Code:
IPM 034
Trial Sponsors:
IPM
Start Date
End Date
November 1, 2013
May 31, 2014
Enrollment:40
Age range:
18 Years ↔
40 Years
Population:Cisgender Women